Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.49 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.48 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.48 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | CA12 | O43570 | 3/20 | 0.46 |
| ▸ | CA7 | P43166 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | CA6 | P23280 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29592373 | 1.00 | GPR35 (0.49) | GPR35AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Water SCHEMBL3706268 | 0.98 | GPR35 (0.47) | GPR35AKR1C4AKR1C3AKR1C2AKR1C1 | |
| Water SCHEMBL31258845 | 0.98 | GPR35 (0.47) | GPR35AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL9478732 | 0.88 | AKR1C4 (0.50) | AKR1C4AKR1C3AKR1C2AKR1C1CA1 | |
| SCHEMBL31169213 | 0.88 | AKR1C4 (0.50) | GPR35AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL2985505 | 0.86 | CA1 (0.53) | AKR1C4AKR1C3AKR1C2AKR1C1CA1 | |
| SCHEMBL460201 | 0.82 | CA1 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL1669745 | 0.81 | ALDH1A1 (0.63) | AKR1C4AKR1C3AKR1C2AKR1C1HSP90AA1 | |
| SCHEMBL24760837 | 0.80 | AKR1C2 (0.48) | GPR35AKR1C4AKR1C3AKR1C2AKR1C1 | |
| SCHEMBL1976832 | 0.80 | CA1 (0.45) | AKR1C4AKR1C3AKR1C2AKR1C1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| CN-117310031-B | Method for detecting halogenated organic pollutants in animal food | 东莞理工学院 | 2024-07-12 | — | — | CN | claimed |
| CN-117310031-A | Method for detecting halogenated organic pollutants in animal food | 东莞理工学院 | 2023-12-29 | — | — | CN | claimed |
| CN-117310039-A | Method for detecting halogenated organic pollutants in plastic of electronic and electrical product | 东莞理工学院 | 2023-12-29 | — | — | CN | claimed |
| CN-117233299-A | Method for detecting halogenated polyphenol in drinking water by solid phase extraction-vacuum centrifugal concentration-liquid chromatography tandem mass spectrometry | 浙江大学 | 2023-12-15 | — | — | CN | claimed |
| CN-113816940-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-21 | — | — | CN | claimed |
| CN-113754634-A | Nicotine salts, co-crystals and salt co-crystal complexes | R.J.雷诺兹烟草公司 | 2021-12-07 | — | — | CN | claimed |
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-09-11 | — | — | US | claimed |
| CN-103838086-B | The composition of the formation antireflection film of reaction product containing isocyanuric acid compound and benzoic acid compounds | 日产化学工业株式会社 | 2017-10-20 | — | — | CN | claimed |
| CN-103838086-A | Composition containing reaction product of isocyanuric acid compound and benzoic acid compound for forming anti-reflection film | NISSAN CHEMICAL IND LTD | 2014-06-04 | — | — | CN | claimed |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATI (US) | 2012-04-12 | — | — | US | claimed |
| WO-2010118241-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION (US) | 2010-10-14 | — | — | WO | claimed |
| US-20090117493-A1 | Anti-Reflective Coating Forming Composition Containing Reaction Product of Isocyanuric Acid Compound with Benzoic Acid Compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2009-05-07 | — | — | US | claimed |
| CN-101268419-A | Composition for forming antireflection film containing reaction product of isocyanuric acid compound and benzoic acid compound | NISSAN CHEMICAL INDUSTRY LTD (JP) | 2008-09-17 | — | — | CN | claimed |
| EP-1939688-A1 | COMPOSITION FOR ANTIREFLECTION FILM FORMATION, COMPRISING PRODUCT OF REACTION BETWEEN ISOCYANURIC ACID COMPOUND AND BENZOIC ACID COMPOUND | Nissan Chemical Industries, Ltd. (JP) | 2008-07-02 | — | — | EP | claimed |
| EP-1697732-A1 | ANALYTE INJECTION SYSTEM | Caliper Life Sciences, Inc. (US) | 2006-09-06 | — | — | EP | claimed |
| WO-2005068993-A1 | ANALYTE INJECTION SYSTEM | CALIPER LIFE SCIENCES, INC. (US) | 2005-07-28 | — | — | WO | claimed |
| US-20050133370-A1 | Analyte injection system | CALIPER LIFE SCIENCES, INC. (US) | 2005-06-23 | — | — | US | claimed |
| EP-0623339-B1 | Use of 4-,4- and 5-, or 4- and 6-substituted derivatives of resorcin in cosmetic or dermopharmaceutical compositions for depigmentation | OREAL (FR) | 1997-07-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10072043-B2 | Inhibitors of protein tyrosine phosphatases | PTPRCAP, PTPRF, PTPRS | GPR35 4703/4885AKR1C4 3835/4885AKR1C3 4367/4885 |
| US-20120088720-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | PTPRCAP, PTPRF, PTPRS | GPR35 4703/4885AKR1C4 3835/4885AKR1C3 4367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.